Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval,…
- Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase II Study of TAK228 in Relapsed Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Phase II Study of TAK228 in Relapsed Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02727777).
- Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC: Complete Statistical AnalysisIndependent statistical analysis of Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05068752).
- Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®: Complete Statistical AnalysisIndependent statistical analysis of Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01827371).
- Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: Complete Statistical AnalysisIndependent statistical analysis of Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02329730).
- Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients: Complete Statistical AnalysisIndependent statistical analysis of Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Phase III Cat-PAD Follow-on Study: Complete Statistical AnalysisIndependent statistical analysis of Phase III Cat-PAD Follow-on Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02040844).
- Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size…
- Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China: Complete Statistical AnalysisIndependent statistical analysis of Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Phase l/II Study of Ruxolitinib for Acute Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Phase l/II Study of Ruxolitinib for Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01251965).
- PHASE ProjectIndependent statistical analysis of Premenstrual Hormonal and Affective State Evaluation (PHASE) Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03862469).
- PHE-LEEPIndependent statistical analysis of Cryotherapy vs. LEEP to Treat Cervical Intraepithelial Neoplasia (CIN) 2/3 Among HIV-positive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Phendimetrazine and Cocaine: Complete Statistical AnalysisIndependent statistical analysis of Phendimetrazine and Cocaine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02233647).
- Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02217709).
- Phenobarbital for Acute Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Phenobarbital for Acute Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01184417).
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced – Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay: Complete Statistical AnalysisIndependent statistical analysis of Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PHI-05Independent statistical analysis of Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PHM2Independent statistical analysis of Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation: Complete Statistical AnalysisIndependent statistical analysis of PHNA, Efficacy of Tretinoin Cream on Post-phototherapy Hyperpigmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03933774).
- PHOMICIndependent statistical analysis of Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04067843).
- PHOTOIndependent statistical analysis of Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Photodynamic Therapy-Induced Immune Modulation: Part III: Complete Statistical AnalysisIndependent statistical analysis of Photodynamic Therapy-Induced Immune Modulation: Part III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03643744).
- PHranceSCaIndependent statistical analysis of A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer: primary endpoint…
- PHSU02Independent statistical analysis of Study of PXL01 Versus Placebo to Inhibit Adhesion Formation After Flexor Tendon Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PHT2Independent statistical analysis of Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Physical Activity and Participation: Complete Statistical AnalysisIndependent statistical analysis of Physical Activity and Participation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268916).
- Physical Health in Midlife: Influences of Adversity and Relationships Over Time: Complete Statistical AnalysisIndependent statistical analysis of Physical Health in Midlife: Influences of Adversity and Relationships Over Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Physical Therapy Intervention for Pelvic Organ Prolapses: Complete Statistical AnalysisIndependent statistical analysis of Physical Therapy Intervention for Pelvic Organ Prolapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06532292).
- Physical Therapy Intervention for Puerperal Mastitis: Complete Statistical AnalysisIndependent statistical analysis of Physical Therapy Intervention for Puerperal Mastitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569136).
- Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With Abdominal Aortic Aneurysms (AAA): Complete Statistical AnalysisIndependent statistical analysis of Physician-Sponsored IDE for Talent Endoluminal Spring Graft System in Patients With Abdominal Aortic Aneurysms (AAA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.: Complete Statistical AnalysisIndependent statistical analysis of Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Physiologic Pacing Registry: Complete Statistical AnalysisIndependent statistical analysis of Physiologic Pacing Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03719040).
- Physiological Flow of Liquids in Healthy Swallowing: Complete Statistical AnalysisIndependent statistical analysis of Physiological Flow of Liquids in Healthy Swallowing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04114617).
- Physiological Flow of Liquids Used in Dysphagia Management (Neuro): Complete Statistical AnalysisIndependent statistical analysis of Physiological Flow of Liquids Used in Dysphagia Management (Neuro): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192358).
- Physiology of GERD and Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Physiology of GERD and Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04292470).
- PICASSOIndependent statistical analysis of A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to